In 2025, Category III codes 0913T and 0914T were introduced to streamline the reporting of percutaneous coronary interventions (PCI) by combining drug-coated balloon (DCB) angioplasty with advanced imaging techniques like intravascular ultrasound (IVUS) or optical coherence tomography (OCT). DCB angioplasty is a minimally invasive technique delivering antiproliferative drugs directly to narrowed or blocked arteries, promoting long-term vessel patency without permanent implants. These new codes reflect the growing role of innovative, precise therapies in coronary artery disease (CAD) management, ensuring accurate documentation and facilitating optimal reimbursement. Understanding key nuances is critical for correct and compliant coding come 2025. Let’s examine the details to score success now and throughout the new year.
Critical Understanding of Coronary Intervention via Drug Delivery Balloon
First, we need to understand what makes each code selection unique. Let’s start with Code 0913T. Code 0931T details PCI utilizing drug-eluting or drug-coated angioplasty and includes mechanical dilation with a non-drug delivery balloon and IVUS or OCT, when performed, on a major coronary artery or graft (left main, LAD, LCX, RCA, ramus intermedius) or a branch of the major coronary artery (LAD, LCX, RCA).
| 0913T | Percutaneous transcatheter therapeutic drug delivery by intracoronary drug-delivery balloon (eg, drug-coated, drug-eluting), including mechanical dilation by nondrug-delivery balloon angioplasty, endoluminal imaging using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) when performed, imaging supervision, interpretation, and report, single major coronary artery or branch |
Code 0914T, however, is an add-on code. This code encompasses PCI utilizing drug-eluting or drug-coated angioplasty and includes mechanical dilation with a non-drug delivery balloon and IVUS or OCT, when performed. It is important to note this add-on code is reported when performed on a separate target lesion in addition to the primary intervention in the same major coronary artery or graft (left main, LAD, LCX, RCA, ramus intermedius) or a branch of the major coronary artery (LAD, LCX, RCA).
| +0914T | Percutaneous transcatheter therapeutic drug delivery by intracoronary drug-delivery balloon (eg, drug-coated, drug-eluting) performed on a separate target lesion from the target lesion treated with balloon angioplasty, coronary stent placement or coronary atherectomy, including mechanical dilation by nondrug-delivery balloon angioplasty, endoluminal imaging using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) when performed, imaging supervision, interpretation, and report, single major coronary artery or branch (List separately in addition to code for percutaneous coronary stent or atherectomy intervention) |
For accurate coding, coders must hold a clear understanding of the procedure itself. Percutaneous transcatheter therapeutic drug delivery by intracoronary drug-coated balloon (DCB) is a minimally invasive procedure used to treat coronary artery disease (CAD). It involves using a specialized balloon catheter to deliver antiproliferative drugs directly to the site of a narrowed or blocked coronary artery during percutaneous coronary interventions (PCI). This approach can be combined with other interventions aimed at restoring blood flow to the heart. DCBs provide long-term vessel patency and may offer comparable outcomes to drug-eluting stents (DES) without the need for permanent implants, making them a valuable option, particularly for in-stent restenosis cases.
With every dollar of reimbursement counting more than ever in the face of payment decline and complex new rules, it’s imperative to make sure your CPT® coding is correct and compliant. Master more cardiology coding topics and break down the complexity with our Cardiology All Access Pass. Find the right subscription and resource tailored to your needs today to make every member of your team successful with 2025 coding.
As of Jan. 1, the Centers for Medicare & Medicaid Services (CMS) initiated a three-year phase-out of the Inpatient-Only (IPO) List, which fundamentally reshapes how
For nearly a decade after the late-2000s Centers for Medicare & Medicaid Services (CMS) policy changes, work Relative Value Units (RVUs) felt like a stable
Please log in to your account to comment on this article.
Expert presenters Kathy Pride, RHIT, CPC, CCS-P, CPMA, and Brandi Russell, RHIA, CCS, COC, CPMA, break down complex fracture care coding rules, walk through correct modifier application (-25, -57, 54, 55), and clarify sequencing for initial and subsequent encounters. Attendees will gain the practical knowledge needed to submit clean claims, ensure compliance, and stay one step ahead of payer audits in 2026.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.
Get clear, practical answers to Medicare’s most confusing regulations. Join Dr. Ronald Hirsch as he breaks down real-world compliance challenges and shares guidance your team can apply right away.
Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
